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Mice Lacking the Orphan G Protein-Coupled
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and proliferative expansion. Proximal events of TCR sig-
naling include activation of Src family kinases (Lck, Fyn),
phosphorylation of TCR components (z), and subse-
quent activation of ZAP70/Syk tyrosine kinases, as
well as recruitment of adaptor molecules (CBL-B, LAT,
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Important downmodulatory mechanisms that ensureDallas, Texas 75390
a return of the immune system to preimmunization levels
after a productive response to a foreign antigen have
been described. Clonal deletion, anergy, and cytokine-Summary
mediated suppression are mechanisms ensuring ho-
meostatic control of the immune system and establish-Mice with a targeted disruption of the gene encoding
ment of peripheral tolerance (Van Parijs and Abbas,a lymphoid-expressed orphan G protein-coupled re-
1998). While induction of central and peripheral toler-ceptor, G2A, demonstrate a normal pattern of T and
ance ensures the elimination and anergy of autoreactiveB lineage differentiation through young adulthood. As
T cells, negative regulatory mechanisms operating atG2A-deficient animals age, they develop secondary
the level of antigenic TCR stimulation are a critical partlymphoid organ enlargement associated with abnor-
of the homeostatic network preventing inappropriate ormal expansion of both T and B lymphocytes. Older G2A-
deregulated T cell-dependent immune responses. Sev-deficient mice (.1 year) develop a slowly progres-
eral molecular components have been identified andsive wasting syndrome, characterized by lymphocytic
their mechanism of action elucidated (Bachmaier et al.,infiltration into various tissues, glomerular immune
2000; Chiang et al., 2000; Daeron et al., 1995; Gorelikcomplex deposition, and anti-nuclear autoantibodies.
and Flavell, 2000; Long, 1999; Lorenz et al., 1996; Perez-G2A-deficient T cells are hyperresponsive to TCR stim-
Villar et al., 1999; Plas and Thomas, 1998; Tivol et al.,ulation, exhibiting enhanced proliferation and a lower
1995). A defect in any one of these critical regulatorsthreshold for activation. Our findings demonstrate
is likely to perturb normal immunological homeostasis,that G2A plays a critical role in controlling peripheral
leading to the development of lymphoproliferative dis-lymphocyte homeostasis and that its ablation results
orders and autoimmunity.in the development of a novel, late-onset autoimmune
Recent studies have underlined the importance of Gsyndrome.
proteins and G protein-coupled receptors (GPCRs),
most notably the chemokine receptor subfamily, in theIntroduction
regulation of immune responses. In many cases, the role
of chemokine receptors is likely to be one of recruitment
In the face of continual exposure to antigenic challenge of T cells to specific sites of the developing immune re-
from the environment, the peripheral lymphoid compart- sponse within secondary lymphoid organs (Cyster, 1999).
ments are maintained at a relatively constant pool size However, certain lymphoid-expressed GPCRs may play
over time (Tanchot et al., 1997). The balance between more direct roles in regulating TCR-dependent signal-
proliferative expansion and elimination of activated or ing. Heterotrimeric G proteins of the Ga16 and Gai sub-
autoreactive cells is tightly regulated at the level of T and class are implicated in the negative regulation of T cell
B lymphocyte antigen receptors. Responses to antigen proliferation. Overexpression of Ga16 in Jurkat T cells
receptor engagement are controlled by an array of other inhibits Concanavalin A (ConA)-induced IL-2 production
cell surface receptors and intracellular molecules that and CD69 upregulation, suggesting that Ga16 may be
regulate proximal and distal signaling events of lympho- involved in the negative regulation of TCR signaling (Lip-
cyte activation (Dustin and Chan, 2000). pert et al., 1997). In addition, Gai2-deficient mice develop
Many of the essential biochemical features of lympho- an autoimmune syndrome during the first 6 months of
cyte activation and differentiation induced by antigen life, characterized by inflammatory bowel disease (Horn-
receptor engagement have been defined. For example, quist et al., 1997). Regulators of G protein signaling
ligation of the T cell receptor (TCR) by antigen/MHC results (RGS) proteins attenuate G protein signaling pathways
in activation of the T cell, progression into the cell cycle, and several are transcriptionally induced in activated
T cells (Beadling et al., 1999). Most notably, RGS2-defi-
cient mice exhibit impaired T cell-dependent immune5 Correspondence: owenw@microbio.ucla.edu
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function associated with reduced T cell proliferative re- typed by Southern blot analysis of tail DNA (Figure 1B).
Heterozygous (G2A1/2) and homozygous (G2A2/2) mu-sponses and IL-2 production (Oliveira-Dos-Santos et al.,
2000). More global involvement of G proteins is indicated tant mice are born with expected Mendelian frequen-
cies. Young G2A2/2 mice are healthy and appear indistin-by their enrichment within the membrane microdomains
(lipid rafts) of activated T cells (Heller et al., 2000), sug- guishable from wild-type litermates. Southern blot
analysis of genomic DNA using G2A cDNA as a probegesting that they and their cognate GPCRs may directly
modulate proximal events during TCR-dependent lym- demonstrates the successful deletion of the G2A gene
at the DNA level (Figure 1C). In addition, RT-PCR analy-phocyte activation.
G2A is an orphan GPCR identified in a search for sis of RNA from G2A2/2 Pre-B and T cells failed to detect
the expression of G2A mRNA, further confirming thatdownstream transcriptional targets of the BCR-ABL ty-
rosine kinase. G2A is expressed predominantly in G2A proteins cannot be made (Figure 1D). These com-
bined data demonstrate that this alteration of the G2Alymphoid tissues and is transcriptionally induced in B
lymphocytes following exposure to genotoxic agents. gene is a loss of expression mutation.
Examination of the expression pattern of murine G2AOverexpression of G2A antagonizes transformation of
fibroblasts by BCR-ABL and results in the accumulation on multiple tissue mRNA blots revealed that the highest
expression is in hematolymphoid tissues like spleen andof cells within G2/M. Expression of G2A in long-term
bone marrow cultures suppresses BCR-ABL-induced thymus (Weng et al., 1998). To further characterize the
pattern of G2A expression in various murine tissues, wepre-B cell expansion (Weng et al., 1998). Recently, we
have established the coupling of G2A to Ga13, leading used the LACZ knockin as a surrogate marker. X-gal
staining and histological analysis of tissue sections de-to activation of RhoA and actin stress fiber formation in
fibroblasts (Kabarowski et al., 2000). These observations rived from G2A1/2 mice confirmed that G2A is expressed
predominantly in lymphoid tissues like bone marrow,implicate a number of possible roles for G2A, including
negative regulation of proliferation and integration of spleen, and thymus (data not shown). Interestingly,
LACZ-expressing cells are present at a low frequencyextracellular signals with cytoskeletal reorganization.
We have generated G2A-deficient (G2A2/2) mice by in lymphoid organs of G2A1/2 mice. This could be due
to low detection limits of this method, as T and B cellshomologous recombination to determine its role in lym-
phocyte development and function. Young G2A2/2 mice are known to contain a b-Gal-inhibitory activity (Elefanty
et al., 1998; Krall and Braun, 2000; Schwarze et al., 1999).appear normal and exhibit no discernible histological
abnormalities of their lymphoid tissues. However, with However, it is also possible that G2A expression may
be restricted to those lymphocytes engaged in specificage, they develop progressive secondary lymphoid or-
gan enlargement associated with an abnormal poly- processes of immunological function or development.
We also observe expression of G2A in testis and kidneyclonal expansion of lymphocytes which dramatically dis-
rupts their normal architecture. Finally, older G2A2/2 (data not shown). In the kidney, G2A is expressed at the
cortical-medullary junction, whereas, in the testis, G2Amice (.1 year of age) succumb to an autoimmune syn-
drome whose late onset distinguishes it from phenotypi- expression is largely confined to mature spermatids. We
do not currently know what role, if any, G2A plays incally similar syndromes arising in mice with targeted
disruptions of genes encoding other regulators of TCR these tissues.
signaling (Bachmaier et al., 2000; Chiang et al., 2000;
Jacobson et al., 1995; Tivol et al., 1995). T cells from Normal T and B Cell Development
young G2A2/2 mice display enhanced in vitro prolifera- in G2A-Deficient Mice
tive responses to TCR crosslinking and costimulation. Compared to wild-type animals, G2A2/2 mice grow and
These observations demonstrate that, although G2A is breed normally. Up to 8 weeks of age, G2A2/2 mice
not essential for normal T and B cell development, it display no gross abnormalities, although rarely an ani-
plays an important homeostatic role in controlling pe- mal will have an enlarged superficial inguinal lymph
ripheral lymphocyte numbers by regulating the thresh- node. Histological analyses of bone marrow, thymus,
old of TCR-dependent activation and proliferation. spleen, lymph nodes, Peyer’s patch, kidney, testis, adre-
nal gland, liver, pancreas, small and large intestine,
brain, heart, lung, skeletal muscle, and skin from wild-Results
type and G2A2/2 mice revealed no morphologic differ-
ences (data not shown).Generation of G2A-Deficient Mice
We used homologous recombination in 129SvJ embry- To determine the potential consequences of loss of
G2A function in T and B lymphoid lineages, we examinedonic stem (ES) cells to disrupt the G2A locus. A targeting
vector was constructed by replacing the second exon the composition and distribution of cell surface markers
in the bone marrow, thymus, spleen, and lymph nodesof the G2A gene, which contains 98% of the total coding
sequence, with IRES-b-galactosidase (LacZ) sequences of young (6–10 weeks of age) G2A2/2 mice. Expression of
TCRab, CD3, CD4, CD8, CD25Ra, Thy1.2, CD44, CD69,driven by the endogenous G2A promoter and a Neomy-
cin resistance gene driven by a cis-linked PGK promoter B220, IgM, IgD, BP-1, CD43, and CD19 was analyzed.
T and B lymphoid compartments of wild-type and G2A2/2(Figure 1A). Chimeric mice generated from targeted ES
cells were bred with BALB/c mice. All phenotypic stud- animals are indistinguishable by these criteria (Figure
2). In addition, proliferative expansion and differentiationies reported in this manuscript were conducted with
mice backcrossed from 3rd to 6th generations onto the of G2A2/2 T and B lymphoid precursors and their progeny
in fetal thymic organ culture (Hashimoto et al., 2000)BALB/c background. Heterozygotes carrying the G2A
null mutation were interbred, and offspring were geno- and long-term Pre-B bone marrow culture (Whitlock and
Autoimmunity in G2A-Deficient Mice
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Figure 1. Targeting Vector for Homologous Recombination into the G2A Locus
(A) Genomic organization of the wild-type G2A allele, structure of the G2A targeting vector, and predicted structure of the correctly targeted
mutant allele.
(B and C) Southern blot analysis of PstI-digested tail genomic DNA hybridized with the external probe B (B) for genotypic determination or
with the internal probe A (C) to determine successful deletion of the G2A gene.
(D) RT-PCR analysis of total RNA derived from splenic T cells (right panels) and BCR-ABL-transformed pre-B cells (left panels), using G2A-
specific primers P1 and P2.
Witte, 1987) are indistinguishable from that of their wild- immunization with T cell-dependent and T cell-indepen-
dent antigens, DNP-KLH and TNP-Ficoll, respectivelytype counterparts (data not shown). Normal develop-
ment of G2A2/2 T lymphoid subsets in fetal thymic organ (Satterthwaite et al., 1998). Both wild-type and G2A2/2
mice are able to mount comparable antibody responsescultures also suggests that migratory responses of thy-
mic precursors and their progeny are not impaired in to both of these antigenic challenges, as determined by
measurement of DNP-specific IgG1 and TNP-specificthe absence of G2A.
Our previous observation that ectopic expression of IgM (data not shown). In addition, animals were chal-
lenged with infectious agents, including Bordetella per-G2A in heterologous cell types delays cell cycle progres-
sion through G2/M (Weng et al., 1998) warranted exami- tussis and Listeria (Harvill et al., 1999; Jensen et al.,
1998). The rates of pathogen clearance were indistin-nation of growth and apoptotic responses in G2A2/2
lymphoid cells. Treatment of wild-type and G2A2/2 B guishable in wild-type and G2A2/2 animals (data not
shown). Taken together, these observations indicatelymphoid and thymic T cells with various doses of ioniz-
ing radiation (IR), etoposide, or dexamethasone in vitro that a functional G2A gene product is not required for
the development and immunological function of T andinduced apoptosis to the same extent and with similar
kinetics as measured by FACS analysis of propidium B lymphocytes in young adult mice.
iodide and anti-Annexin-V antibody stained cells. In ad-
dition, we found no significant differences in cell cycle Lymphoid Expansion and Disruption of Lymph Node
Architecture in Older G2A-Deficient Miceparameters or the rate and degree of apoptosis in wild-
type versus G2A2/2 T and B lymphoid cells following While young G2A2/2 mice exhibit no discernible histolog-
ical and cellular abnormalities of their lymphoid tissues,serum deprivation in vitro or in vivo exposure of animals
to varying doses of IR (data not shown). examination of older mice reveals progressive develop-
ment of various anomalies which become more frequentTo assess the integrity of humoral immune responses
in young adult G2A2/2 mice (2–4 months old), we mea- and severe with age, indicative of a disregulated immune
system. G2A2/2 mice greater than 1 year of age exhibitsured basal levels of serum immunoglobulin (Ig) produc-
tion in unimmunized wild-type and G2A2/2 mice. Compa- gross enlargement of these secondary lymphoid organs
(Figure 3A). These changes were seen uniformly inrable levels of different Ig isotypes (IgM, IgG1, IgG2a,
IgG2b, IgG3, IgA) were observed, indicating that G2A2/2 G2A2/2 mice examined from multiple litters. Thymi in
wild-type and G2A2/2 animals at these ages are not en-B lymphocytes are capable of isotype switching and a
normal balance of Ig isotype production. We also mea- larged and indistinguishable. The lymphadenopathy re-
sults in disruption of normal lymph node architecturesured the responses of wild-type and G2A2/2 mice to
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Figure 2. Normal T and B Lymphoid Development in G2A2/2 Mice
Flow cytometric analysis of thymic, splenic, lymph node, and bone
marrow cells from 8-week-old wild-type mice (left panels) and
8-week-old G2A2/2 mice (right panels). Proportions of cells in each
quadrant are indicated as percentages.
(Figure 3B) and is associated with a 3- to 6-fold increase
of both CD41 and CD81 T lymphocyte numbers and a
2- to 3-fold increase of B2201 B lymphocyte numbers
compared to wild-type (average 7.7 3 106 CD41, 12.6 3
106 CD81 T cells, and 15.7 3 106 B2201 B cells for G2A2/2
lymph nodes versus 3.87 3 106 CD41, 1.8 3 106 CD81 Figure 3. Enlargement of Lymphoid Organs and Disruption of Follic-
T cells, and 6.0 3 106 B2201 B cells for wild-type lymph ular Architecture in Older G2A-Deficient Mice
nodes). Splenomegaly is associated with expansion of (A) Peripheral lymph nodes and spleens from a typical 15-month-old
both B2201 B lymphocyte numbers and a 3- to 5-fold G2A2/2 mouse (right panel) and its wild-type littermate (left panel).
(B) H&E-stained sections of lymph nodes from wild-type (upperincrease of CD41 and CD81 T lymphocyte numbers
panel) and G2A2/2 (lower panel) mice.compared to wild-type (average 45.6 3 106 CD41, 20.6 3
(C) PCR analysis of TCR (left panel) and Ig (right panel) re-106 CD81 T cells, and 83.2 3 106 B2201 B cells per
arrangement. Lanes 1–2, G2A2/2 spleens; lanes 3–5, G2A2/2 lymph
G2A2/2 spleen versus 16.2 3 106 CD4 1, 5.5 3 106 CD81 nodes; lane 6, wild-type spleen; lane 7, DNA size markers (GIBCO).
T cells, and 64.3 3 106 B2201 B cells per G2A1/1 spleen). Pictures are representative of at least ten animals.
This increase in lymphoid numbers does not appear to
result from malignant expansion of a clonal nature (Fig-
ure 3C), since PCR amplification of rearranged TCR and into various organs. Lungs of G2A2/2 mice have promi-
nent perivascular and interalveolar infiltration of mono-Ig junction and diversity regions (Kawamoto et al., 2000)
in G2A2/2 mice (lanes 1–5) revealed no evidence of clon- nuclear cells (Figure 4A). Clusters of lymphocytes are
present in the liver parenchyma of these G2A2/2 animalsality in comparison to wild-type spleen (lane 6).
(Figure 4B).
Affected mice also have increased immunoglobulinAutoimmunity in Older G2A-Deficient Mice
G2A2/2 mice appear healthy until 15–16 months of age, levels of different isotypes (IgG1 and IgA) as well as
elevated levels of both k and l light chains (Figure 5A).when they begin showing signs of wasting. Wild-type
littermates show no detectable signs of illness at this Deposition of immunoglobulin complexes is detected in
the glomeruli of older G2A2/2 mice, whereas little deposi-age. Histological examination of various tissues from
these G2A2/2 mice reveals heavy lymphocytic infiltration tion of IgG is detected in those of age-matched wild-type
Autoimmunity in G2A-Deficient Mice
565
Figure 4. Photomicrograph of Lung and Liver Sections from Wild-
Type and G2A2/2 Mice Stained with H&E
Histology of lung (A) and liver (B) tissues from a typical 15-month-
old wild-type mouse (lower panel) and a 15-month-old G2A2/2 mouse
(upper panel), showing perivascular infiltration of mononuclear cells.
Three mice per group have been analyzed, and the representative
Figure 5. Older G2A-Deficient Mice Develop an Autoimmune Syn-microscopic views are presented. Right panels, 1003; left panels,
drome4003.
(A) Serum immunoglobulin levels in wild-type and G2A2/2 mice. In-
creased immunoglobulin levels of IgG1 and IgA (left panel) as well
as elevated levels of both k and l light chains (right panel) in G2A2/2littermates (Figure 5B). As one of the primary causes for
mice.deposition of immune complexes in the glomeruli is the
(B) Paraffin sections of kidney tissue from wild-type (lower panels)
presence of autoantibodies against nuclear antigens, and G2A2/2 (upper panels) mice reveal glomerular immunoglobulin
we examined sera from wild-type and G2A2/2 mice by in- deposition. Left panels, 1003; right panels, 4003.
direct immunofluorescence on Hep-2 cells (Di Cristofano (C) Indirect immunoflourescence analysis of serum autoantibodies
in wild-type and G2A2/2 mice. Autoantibodies reacting against nu-et al., 1999). Anti-nuclear autoantibodies (ANAs) show-
clear antigens are present in serum from G2A2/2 mice (left panels,ing speckled patterns and decorating mitotic figures are
[C1] and [C2]) but not in wild-type mice (right panels, [C3] and [C4]).readily detectable in G2A2/2 sera and are absent in wild-
type sera (Figure 5C). Together with the emergence of
lymphadenopathy in aging G2A2/2 mice, these observa- G2A2/2 mice, the age-related development of lymphade-
nopathy and autoimmunity suggests a defect in normaltions are consistent with the development of a late-onset
non-organ-specific autoimmune syndrome, whose latency regulatory mechanisms controlling the level or threshold
of antigen receptor-dependent immunological activa-distinguishes it from other murine models of autoimmu-
nity displaying otherwise similar pathological features tion. To address the question of whether the lymphopro-
liferative phenotype of older G2A2/2 mice is associated(Bachmaier et al., 2000; Chiang et al., 2000; Hornquist
et al., 1997; Jacobson et al., 1995; Tivol et al., 1995). with altered responses to antigen receptor stimulation,
we tested young animals (6–10 weeks of age) prior to
the development of any overt signs of histopathologicalG2A-Deficient T Cells Exhibit Enhanced Proliferative
Responses to T Cell Receptor Stimulation abnormalities. G2A2/2 peripheral T cells were stimulated
in vitro by plate-bound anti-CD3e antibodies and prolif-When considered together with the normal lymphoid
development and immune function observed in young eration measured by tritiated thymidine ([3H]thymidine)
Immunity
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Figure 6. G2A2/2 T Cells but Not B Cells Ex-
hibit Hyperproliferative Responses to Antigen
Receptors Crosslinking Stimulation In Vitro
Proliferation of peripheral T cells from young
wild-type and G2A2/2 mice stimulated by vari-
ous concentrations of anti-CD3e antibody
alone (A) or with CD28 costimulation (B). Pro-
liferation was assessed in triplicate by
[3H]thymidine incorporation during the last 12
hr of culture. FACS analysis of propidium io-
dide-stained G2A2/2 (C) and wild-type (D) T
cells 36 hr following anti-CD3e stimulation.
Equal proliferative responses of splenic B
cells from wild-type and G2A2/2 mice by anti-
IgM crosslinking (E) or LPS (F).
incorporation. Compared to their wild-type equivalents, cells, demonstrating that increased survival is not likely
a major component of the hyperproliferative phenotypeG2A2/2 T cells exhibit enhanced proliferative responses
to stimulation with anti-CD3e antibodies across a range (Figures 6C and 6D).
We also analyzed antigen receptor-dependent prolif-of concentrations (Figure 6A). Importantly, this is not asso-
ciated with abrogation of CD28 costimulation requirement erative responses of B cells in vitro (Satterthwaite et
al., 1998). Both wild-type and G2A2/2 peripheral B cellsfor IL-2 production in G2A2/2 T cells, as levels of IL-2 are
comparably low in supernatants of anti-CD3e antibody displayed equivalent proliferative responses to surface
IgM crosslinking as well as lipopolysaccharide (LPS)stimulated wild-type and G2A2/2 cultures (data not shown).
Suboptimal concentrations of anti-CD3e antibodies stimulation (Figures 6E and 6F), suggesting that either
the primary action of G2A is in T cells rather than in B(0.25–0.5 mg/ml), which barely induce a proliferative re-
sponse in wild-type T cells, nevertheless elicit a signifi- cells or that loss of G2A function in B cells is compen-
sated by one or more homologous GPCRs. Althoughcant proliferative response in G2A2/2 lymphocytes, sug-
gesting lower TCR thresholds in the latter (Figure 6A). B lymphocytes from young G2A-deficient mice exhibit
normal proliferative responses to surface IgM crosslink-Costimulation of wild-type and G2A2/2 T cells with
anti-CD3e mAb plus anti-CD28 mAb, or anti-CD3e mAb ing by polyclonal F(ab9)2 anti-IgM, we observe that B
lymphocytes from old, autoimmune G2A-deficient miceplus IL-2, similarly induces greater proliferative re-
sponses in G2A2/2 versus G2A1/1 lymphocytes, despite are hyperresponsive (z2.5-fold) compared to B lympho-
cytes from age-matched wild-type mice (data notboth being increased above that elicited by anti-CD3e
antibody alone (Figure 6B). Importantly, the rate and shown). This observation may reflect the presence of
a population of autoreactive B lymphocytes in theseextent of apoptosis in stimulated cultures of wild-type
and G2A2/2 T lymphocytes are indistinguishable as mea- animals, although other explanations are possible and
are being investigated.sured by FACS analysis of propidium iodide-stained
Autoimmunity in G2A-Deficient Mice
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Figure 7. Self-Reactive, Hyperresponsive, and Altered Threshold of TCR-Dependent Activation in G2A2/2 T Cells
Syngeneic (A) and allogenic (B) mixed lymphocyte reactions using lymph node T cells (from 6- to 8-week-old mice) as responder cells and
autologous splenic B cells or B6-derived B cells as stimulators. (C) Kinetics of stimulation of wild-type and G2A2/2 T cells by 5 mg/ml anti-
CD3e antibody. T cell proliferation was assessed in triplicate by measurement of [3H]thymidine incorporation during a 12 hr period ending at
the indicated time points following stimulation.
In addition, we performed syngeneic and allogenic Discussion
mixed lymphocyte reactions (MLRs), using autologous
splenic B cells or B6-derived B cells as stimulators, An essential role for the orphan GPCR G2A in homeo-
respectively (Miyazaki et al., 1997). Lymph node-derived static mechanisms regulating lymphocyte numbers is
T cells from G2A2/2 mice responded with significantly demonstrated by the development of lymphadenopathy
enhanced proliferation in both syngeneic and allogenic and autoimmune disease in older G2A2/2 animals. Al-
MLRs compared to T cells from wild-type animals (Fig- though G2A function is dispensable for normal T and B
ures 7A and 7B). Interestingly, the hyperresponsiveness lymphopoiesis and immune function in young mice, it
of G2A2/2 T cells is even more pronounced in MLRs. This is possible that this could reflect a redundancy of func-
suggests an impact of G2A upon one or more biologi- tion in the hematopoietic system, with compensatory
cal processes regulating MHC-dependent T/B cell in- activity of one or more homologous GPCRs rescuing
teraction and immunological activation, which are less the effect of G2A deficiency. In this respect, G2A exhibits
adequately recapitulated by engagement of TCR and a high degree of homology to several orphan GPCRs,
costimulatory receptors by plate-bound antibodies. Im- most notably TDAG8, a GPCR expressed predominantly
portantly, proliferative responses of wild-type T cells are in T cells (Choi et al., 1996). Interestingly, the human genes
negligible in syngeneic MLRs, while those of G2A2/2 encoding G2A and TDAG8 are both located on chromo-
T cells are high, suggesting that autoreactive T cells are some 14q32, a region in which abnormalities are fre-
present in G2A2/2 animals (Bachmaier et al., 2000). quently found in T cell leukemias and lymphomas (Kyaw
The responsiveness of G2A2/2 T cells to suboptimal et al., 1998; Weng et al., 1998). This suggests that G2A
concentrations of anti-CD3e antibody suggests that the and TDAG8 may be representative members of a subfam-
activation thresholds of antigen receptors may be al- ily of GPCRs with overlapping functions in lymphocytes.
tered in G2A2/2 T cells. To explore this issue further, we The lymphadenopathy developing in aging G2A2/2
performed kinetic experiments in which [3H]thymidine mice is associated with enlargement of both T and B
was added to T cells at various time points following dep- lymphocyte pools. However, only T lymphocytes are
osition onto anti-CD3e antibody-coated plates. These
hyperresponsive to antigen receptor stimulation in vitro,
studies revealed that proliferative responses of G2A2/2
and dose response and kinetic analysis provides evi-T cells are not only greater but occur at earlier time
dence that their TCR thresholds are lower. To determinepoints compared to wild-type T cells, when stimulated
whether this is associated with abnormal activation ofwith equivalent concentrations of anti-CD3e antibody
proximal signaling pathways, we examined global tyro-(Figure 7C). This suggests that activation thresholds are
sine phosphorylation of cellular proteins in T cells fromlower in G2A2/2 T cells. Expression of the high-affinity
young wild-type and G2A2/2 mice following crosslinkingIL-2 receptor (CD25a) is equivalent in wild-type and
of CD3/TCR complexes. However, we observe consider-G2A2/2 T cells before and after stimulation (data not
able variability between animals with respect to totalshown), suggesting that increased responsiveness to
cellular phosphotyrosine levels in G2A2/2 T cells bothsuboptimal concentrations of IL-2 does not account for
prior to and following stimulation. In some preparations,this kinetic difference. In addition, expression of the
levels of tyrosine phosphorylation are comparable inT cell early activation marker CD69 is comparable be-
wild-type and G2A2/2 T cells, while, in others, G2A2/2tween wild-type and G2A2/2 T cells prior to and 12–48
T cells exhibit globally elevated levels of tyrosine phos-hr following activation (data not shown), suggesting that
phorylation. We are exploring this phenomenon furtherhyperresponsiveness of G2A2/2 T cells is not associated
with an “activated” phenotype. by examining the phosphorylation status and activity
Immunity
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of individual signaling components in response to TCR flammatory response at one or more anatomical sites
following induction of a pathogen-specific immune re-stimulation from multiple animals at different ages.
Although the molecular basis underlying the hyperre- sponse. However, development of chronic autoimmune
disease characterized by lymphocytic infiltration andsponsiveness of G2A2/2 T lymphocytes to TCR stimula-
tion is presently unknown, several possible explanations tissue damage probably requires additional biological
events and is dependent upon genetic factors (Andrecan be proposed based on our knowledge of the biologi-
cal properties of G2A. G2A activates RhoA, leading to et al., 1996; Ohteki et al., 1999). In this respect, if thresh-
olds for TCR activation are abnormally low and prolifera-actin rearrangement via Ga13 (Kabarowski et al., 2000;
Zohn et al., 2000), suggesting that G2A may function tive responses high, this could have a significant impact
on the fate of antigen-specific T cells which crossreactto regulate the most proximal events of T lymphocyte
activation, perhaps at the level of TCR/cytoskeleton in- with related self-ligands expressed at levels too low to
otherwise precipitate overt autoimmune disease. Al-teraction. Increased proliferative responses of G2A2/2
T cells to PMA/Ca-ionophore (data not shown) suggests though the proliferative and kinetic responses of G2A-
deficient T cells to suboptimal concentrations of stimu-that loss of G2A function may influence proliferation
induced by stimuli in addition to those acting directly latory antibody suggest that lower TCR thresholds may
be the primary defect responsible for the lymphadeno-upon the TCR and that G2A may act downstream of the
T cell receptor. However, it is possible that lower TCR pathy and autoimmunity, we cannot exclude the possi-
bility that additional cell types and mechanisms are in-threshold also underlie or at least contribute to the hy-
perresponsiveness of G2A2/2 T cells to stimuli acting down- volved. Nevertheless, environmental factors such as
infection undoubtedly influence the development ofstream of the TCR in an additive/synergistic manner.
The normal development and distribution of CD41CD81, overt autoimmunity. It is possible that exposure to inter-
mittent bouts of antigenic challenge during the lifetimeCD42CD82, CD41, and CD81 T cells in the thymus of
G2A2/2 mice suggests that mechanisms governing posi- of G2A2/2 mice conspire to precipitate overt autoimmune
disease. In this respect, manipulation of housing condi-tive and negative selection involved in central tolerance
are not responsible for the emergence of autoimmunity. tions to vary the frequency of antigen encounter may
influence the latency for onset of lymphadenopathy andAdditionally, the major pathological features of the auto-
immune syndrome emerging in G2A2/2 animals are most autoimmune disease.
The increased proliferative response of G2A2/2 T cellssimilar to the human disease Systemic Lupus Erythema-
tosus (SLE) (Nishimura et al., 1999). An important ques- to TCR engagement indicates a role for G2A in the regu-
lation of lymphocyte growth and homeostasis. Pres-tion, therefore, is how the hyperresponsiveness of
G2A2/2 T cells to TCR crosslinking in vitro relates to this ently, the mechanism of action of G2A in T cell activation
is unknown, and further studies are underway in ourlate-onset lymphoproliferative autoimmune syndrome
which develops in vivo. Compared to G2A2/2 mice, overt laboratory to dissect downstream signal transduction
pathways. While Ga13-dependent pathways are impli-lymphoproliferative disease and autoimmunity develops
relatively early in mice with targeted disruptions of genes cated by previous studies (Kabarowski et al., 2000), ge-
netic studies have illustrated the involvement of otherencoding CBL-B, CTLA4, FAS (CD95), or FAS ligand,
consistent with their roles as direct regulators of prolifer- heterotrimeric G proteins in T cell-dependent immune
function. For example, Gai2-deficient mice develop auto-ative and apoptotic pathways in activated T cells (Bach-
maier et al., 2000; Chiang et al., 2000; Jacobson et al., immune disease characterized by an inflammatory
bowel syndrome. Prior to the onset of identifiable symp-1995; Tivol et al., 1995). Importantly, the rate and extent
of apoptosis in TCR-stimulated cultures of wild-type and toms, T lymphocytes from Gai2-deficient mice exhibit
profound maturational alterations and functional abnor-G2A2/2 T cells are indistinguishable, demonstrating that
increased thymidine incorporation in the latter is not the malities, including hyperproliferative responses to anti-
CD3e stimulation (Rudolph et al., 1995). At the biochemi-result of suppressed activation-induced apoptosis but
rather increased cycling. Thus, it is possible that deregu- cal level, Gai2 may play a negative regulatory role in
T cells via receptor-dependent inhibition of adenylyl cy-lated proliferative responses of T cells subverts normal
peripheral tolerance mechanisms in G2A2/2 mice, re- clases (Hornquist et al., 1997; Rudolph et al., 1995). In
light of the phenotypic similarities between G2A2/2 andsulting in the expansion of autoreactive T cells, which
in turn activate autoreactive B cells. In this respect, Gai2-deficient animals, further biochemical and genetic
studies are warranted to determine whether G2A cou-thresholds of TCRs are primary determinants of the out-
come following encounter with self-antigens: tolerance ples to Gai2 in T cells.
In conclusion, the results presented here demonstrateor immunological activation (Van Parijs and Abbas,
1998). Certainly, the proliferative responses of G2A2/2 the importance of G2A function in the homeostatic regu-
lation of T lymphocyte populations. Additional studiesT cells in syngeneic MLRs suggests that autoreactive
T cells are present in G2A2/2 mice (Bachmaier et al., employing genetic crosses to make compound knock-
out mice will determine whether G2A functionally over-2000). Considering the multiple susceptibility factors in-
volved in human SLE (Sullivan, 2000), we cannot at pres- laps with other GPCR family members, including TDAG8,
as well as other molecules with regulatory roles in lym-ent exclude the possibility that dendritic as well as other
hematopoietic cell types may play a role in the autoim- phocyte activation. As a unique animal model of late-
onset autoimmunity, G2A-deficient mice should contrib-mune pathology.
Molecular mimicry has been proposed as one link ute to our understanding of the pathogenesis of human
autoimmune and other immunological disorders. In ad-between infection and autoimmunity (Albert and Inman,
1999). Due to promiscuity of TCR binding, crossreactive dition, the suitability of GPCRs as targets of drug-based
therapeutic intervention promises that further charac-ligands expressed in normal tissues may evoke an in-
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bedded in paraffin. Sections (4 mm thick) were stained with hematox-terization of G2A function in T lymphocytes and iden-
ylin and eosin (H&E) as previously described (Gorelik and Flavell,tification of its ligand may uncover clinical benefits
2000). For immunohistochemical studies of immunoglobulin com-of modulating G2A activity in the treatment of autoim-
plex deposition, paraffin sections of kidney tissue were baked over-
mune disease. night at 608C, deparaffinized with xylene, rehydrated, and pretreated
with rat serum. The sections were subsequently stained with biotin-
Experimental Procedures ylated rat antiserum against mouse Ig (PharMingen), followed by
incubation with streptavidin and biotinylated horseradish peroxi-
Generation of G2A-Deficient Mice dase complex (DAKO) according to the manufacturer’s instructions.
The G2A knockout targeting vector was constructed from a 14 kb Sections were developed with diaminobenzidine tetrahydrochloride
NotI fragment of genomic DNA isolated from a 129-Sv mouse geno- (DAB) (Sigma) and counterstained with hematoxylin. ANAs were
mic library, using G2A cDNA as a probe. A 3.6 kb BstXI-HpaI frag- detected in serum dilutions of 1:25; 1:50, and 1:100 by indirect
ment containing exon 2-derived coding sequences for the entire C immunoflourescence on Hep-2 cells from IMMCO (Buffalo, New
terminus and all intracellular and extracellular loops of G2A was York) according to the manufacturer’s instructions (Di Cristofano et
replaced by a 4.5 kb fragment encoding promoterless IRES-LacZ al., 1999).
sequences and a 1.5 kb PGK1-Neo resistance cassette flanked by For X-gal staining, mice were anesthetized with ketamine (1.5 mg/
Plox. The vector can be linearized with NotI and contains 5 kb of mouse) and subjected to total body perfusion with 4% paraformal-
59 flanking sequence homology and 3 kb of 39 flanking sequence dehyde in PBS. Tissues were harvested, equilibrated in 30% sucrose
homology. A 1 kb HpaI-NotI fragment immediately downstream of in PBS overnight at 48C, and subsequently embedded in OTC me-
the 39 sequence homology was used as the external probe for South- dium (Tissue-Tek). Frozen sections were sliced with a cryostat and
ern blot hybridization to check for homologous recombination. mounted on superfrost microscope slides (Fisher Scientific). Cryo-
The targeting vector was electroporated into 129SvJ ES cells stat sections were postfixed with 4% paraformaldehyde, stained
(Genomes System). Southern blot analysis of 150 Neomycin-resis- with X-gal at 308C overnight, and counterstained with neutral red.
tant colonies yielded four positive clones. ES cells from these indi- The X-gal reaction mixture comprises 1 mg/ml 4-chloro-5-bromo-
vidual positive clones were injected into blastocysts harvested from 3-indolyl-b-galactoside (X-gal), 4 mM potassium ferrocyanide, 4 mM
C57BL/6 mice (UCLA Transgenic Facility). Chimeric males from two potassium ferricyanide, and 2 mM magnesium chloride in PBS.
independent ES cell clones were crossed with BABB/C females.
Germline transmission of the G2A mutant allele was detected by In Vitro Proliferation Assays
Peripheral B or T cells from lymph nodes and spleen were isolatedSouthern blot analysis of tail DNA from F1 offsprings. G2A homozy-
using the Minimacs magnetic bead system (Miltenyi Biotec, Inc.,gous (2/2) mice were generated by interbreeding heterozygous
Auburn, CA) according to the manufacturer’s instructions. In brief,(1/2) mice. All animals were housed in the conventional animal
single-cell suspensions were depleted of red blood cells by hypo-facility at UCLA (Los Angeles, California).
tonic lysis and macrophages by plastic adherence prior to incuba-
tion with anti-B220 microbeads. T or B cell-enriched populationsRNA and PCR Analysis
were .90% pure by FACS analysis. B2201 B cells or CD31 T cellsAn RT-PCR method was used to measure the G2A RNA levels as
were seeded into 96-well plates at 2.5 3 105 cell per well in RPMIpreviously described (Weng et al., 1998). In brief, RNA was isolated
with 10% heat-inactivated FCS. B2201 B cells were incubated withfrom either splenic T cells or BCR-ABL-transformed Pre-B lympho-
various concentrations of goat anti-mouse IgM F(ab9)2 fragmentscytes (Weng et al., 1998). First-strand cDNA was synthesized from
(Jackson ImmunoResearch Labs) or LPS (Diffco). CD31 T or total5 mg of total RNA, using the Superscript preamplification system
lymph node cells were cultured in the presence of various concen-(GIBCO/BRL). Using G2A-specific primers P1 (TAGCGGTCGCAG
trations of ConA (Pharmacia) or plate-bound anti-CD3e antibodyGAAATGCAG) and P2 (CAGGACTGGCTTGGGTCATT), 10% of the
(PharMingen) with or without anti-CD28 antibody (PharMingen).first-strand cDNA synthesis product was subsequently used for
[3H]thymidine (1 mCi) (NEN Life Science Products) was added intoPCR. Glyceraldehyde 3-phosphate dehydrogenase (G3PDH) control
each well at the indicated time points for 12 hr, and [3H]thymidineamplimer set (CLONTECH) was included as a control to ensure
incorporation was measured by scintillation counting as describedequivalent template levels and quality of RNA. For PCR analysis of
previously (Miyazaki et al., 1997).TCR and Ig rearrangement, genomic DNA was isolated from spleen
For analysis of tyrosine phosphorylation, T cell stimulation wasand lymph nodes of old mice, and 50 ng was used as templates for
performed as previously described (Murphy et al., 1998). In brief,PCR amplification. Primers are as follows: Db2 (GCACCTGTGGG
purified T cells were incubated with anti-CD3e antibody (5 mg/ml)
GAAGAAACT), Jb2.6 (TGAGAGCTGTCTCCTACTATCGAT) for TCR
on ice for 20 min, washed, and subsequently incubated with goat
rearrangement and DSF (AGGGATCCTTGTGAAGGGATCTACTACT
anti-hamster IgG (5 mg/ml) (Jackson ImmunoResearch Labs) on ice
GTG), and JH4 (AAAGACCTGCAGAGGCCATTCTTACC) for Ig rear- for a further 20 min. CD3/TCR complexes were crosslinked by shift
rangement. PCR analysis was performed as previously described to 378C for the indicated times. Following stimulation, T cells were
(Kawamoto et al., 2000), and amplified DNA products were electro- washed once in ice-cold PBS and subsequently lysed in ice-cold
phoresed on a 1.2% agarose gel. Triton X-100 buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM
EDTA, 1 mM sodium orthovanadate, 1 mM NaF, 1 mM PMSF, 1%
Cell Surface Staining and Flow Cytometric Analysis Triton X-100, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and 10 mg/ml
Single-cell suspensions from lymph nodes, spleen, bone marrow, bestatin). Cleared lysates were run on 10%–16% gradient SDS-
or thymus were depleted of red blood cells by hypotonic lysis and polyacrylamide gels and proteins transferred onto nitrocellulose.
stained with combinations of the following antibodies from Phar- Membranes were immunoblotted with 4G10 antiphosphotyrosine anti-
Mingen (San Diego, CA), unless otherwise stated: PE-conjugated body (Upstate Biotechnology) followed by incubation with horse-
anti-B220, FITC-conjugated anti-IgM, PE-conjugated anti-BP-1, PE- radish peroxidase conjugated goat anti-mouse secondary antibody
conjugated anti-CD43, PE-conjugated anti-CD19, Tri-color-conju- (Bio-Rad). Signal was detected by enhanced chemiluminescence
gated anti-B220 (CalTag), FITC-conjugated anti-TCRab, FITC-con- (ECL) following the manufacturer’s recommendation (Amersham).
jugated anti-CD3, Biotin-conjugated anti-CD25Ra, FITC-conjugated
anti-Thy-1.2, PE-conjugated anti-CD4, FITC-conjugated anti-CD8, Mixed Lymphocyte Reactions
PE-conjugated anti-CD44, FITC-conjugated anti-CD69, PE-conju- Responder lymph node T cells were cultured at various ratios with
gated anti-Ter119, PE-conjugated anti-Gr1, and FITC-conjugated stimulators (2500 rads irradiated splenic cells) from the same animal
anti-Mac1 (Boehringer Mannheim Corp.). Data was acquired on a for syngeneic MLRs or from C57BL/6 mice for allogenic MLRs. At the
FACScan (Becton Dickinson) and analyzed using CellQuest soft- indicated time points, proliferation was assessed by [3H]thymidine
ware. Live cells were gated based on forward and side scatter. incorporation during the last 12 hr of culture (Miyazaki et al., 1997).
Histological and Immunohistochemical Analysis T Cell-Dependent and T Cell-Independent Immune Responses
Tissue specimens were harvested and fixed with 10% formalin in To induce antibody responses to T cell-dependent antigen, mice
were immunized intraperitoneally with 100 mg of DNP-KLH (Calbio-phosphate-buffered saline (PBS) for 1 day and subsequently em-
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chem) in incomplete Freund’s adjuvant (GIBCO-BRL, Gaithersburg, Dustin, M.L., and Chan, A.C. (2000). Signaling takes shape in the
immune system. Cell 103, 283–294.MD), boosted on day 21 with 50 mg of DNP-KLH in PBS, and bled
on days 14 and 28. For T cell-independent antibody responses, Elefanty, A.G., Begley, C.G., Metcalf, D., Barnett, L., Kontgen, F.,
mice were immunized intraperitoneally with 10 mg of TNP-Ficoll and Robb, L. (1998). Characterization of hematopoietic progenitor
(Biosearch Technology, Inc.) in incomplete Freund’s adjuvant cells that express the transcription factor SCL, using a lacZ “knock-
(GIBCO-BRL) and bled 7 days later. Serum immunoglobulins and in” strategy. Proc. Natl. Acad. Sci. USA 95, 11897–11902.
DNP-specific or TNP-specific antibody titers were measured by en-
Gorelik, L., and Flavell, R.A. (2000). Abrogation of TGFb signaling
zyme-linked immunosorbent assay as described previously (Sat-
in T cells leads to spontaneous T cell differentiation and autoimmune
terthwaite et al., 1998).
disease. Immunity 12, 171–181.
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